1 results
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2023-503554-12-00 check the CTIS register for the current data. The primary objective of the study is to describe the pharmacokinetics of Nivolumab (how quickly it is absorbed by the body) when…